Skip to main content

Table 3 Select population characteristics

From: A meta-review of evidence on heart failure disease management programs: the challenges of describing and synthesizing evidence on complex interventions

Reporting of population characteristics

  

No information on co-morbidities

7/15

[24, 25, 29, 30, 32, 33, 35]

Incomplete or no data on NYHA Classification

10/15

[9, 23, 24, 26, 27, 29, 30, 33, 35–37]

No data on NYHA Classification

4/15

[23, 26, 27, 30]

Range of NYHA Classification only

6/15

[24, 25, 28, 31, 32, 37]

Information on LVEF

6/15

[25, 29, 31, 34, 36, 37]

Summaries of ACE-I and BB medication treatments

3/15

[32, 36, 37]

  1. aNYHA, New York Heart Association
  2. bLVEF, Left Ventricular Ejection Fraction
  3. cACE-I, Ace-Inhibitor
  4. dBB, Beta Blocker